-
Mashup Score: 13#TTLC24 - TTLC24 - Fairmont Miramar Hotel & Bungalows - 2 month(s) ago
IASLC Member Registration Opens November 17, 2023 Abstract Submission Closes December 15, 2023 (23:59 MST) Abstract Notifications January 4, 2024 Conference in Santa Monica, California February 21-24, 2024 Discover the pinnacle of lung cancer education and innovation at the IASLC 2024 Targeted Therapies of Lung Cancer Meeting! Prepare yourself for an extraordinary experience that will elevate your expertise and propel your career to new heights. Deepen your lung cancer knowledge and play a role in
Source: iaslc.eventsair.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Program - TTLC24 - Fairmont Miramar Hotel & Bungalows - 2 month(s) ago
Event Time – (UTC-08:00) Pacific Time (US & Canada) Wednesday, February 21, 2024 Thursday, February 22, 2024 Friday, February 23, 2024 Saturday, February 24, 2024 …
Source: iaslc.eventsair.comCategories: General Medicine News, Oncologists1Tweet-
RT @lcrf_org: @IASLC Targeted Therapies #TTLC24 starts tomorrow! View the whole program here: https://t.co/JPuZsQOh5T https://t.co/nighOY8o…
-
-
Mashup Score: 49Welcome Message - TTLC24 - Fairmont Miramar Hotel & Bungalows - 2 month(s) ago
Dear Colleagues and Friends, The IASLC 2024 Targeted Therapies of Lung Cancer Meeting will take place February 21-24, 2024. This will be the final year the meeting is held at the Fairmont Miramar in Santa Monica, California before moving to Huntington Beach in 2025. We are thrilled to invite you to join us for this engaging face-to-face meeting but to enhance the participant experience and…
Source: iaslc.eventsair.comCategories: General Medicine News, Hem/OncsTweet-
Thrilled that its T-2d to #TTLC24! We have put together a program with phenomenal speakers, and look forward to seeing everyone in person! #LCSM @LeciaSequist @JoelNealMD @karenkellymd @IASLC https://t.co/SZX2Iup63X
-
-
Mashup Score: 1The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC - 5 month(s) ago
To explore the association of the effective dose to immune cells (EDIC) with disease control, lymphopenia, and toxicity in patients with non-small cel…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet-
RT @PennThalheimer: 📰Must read in @RadiotherapyOn1(Vol. 190): https://t.co/OSkK8xeDdc @PC3Innovation faculty along with @PennThalheimer's…
-
-
Mashup Score: 64
Original Article from The New England Journal of Medicine — Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
Source: www.nejm.orgCategories: General Medicine News, Oncologists1Tweet-
The field of Thoracic Oncology is moving faster than we can keep up! Another @NEJM article, this time on AEGEAN- first reported @AACR, now published, with full results of peri-operative Durvalumab in resectable #NSCLC @ESMO_Open #ESMO23 https://t.co/jQao1gRESw Congrats to… https://t.co/y5V3G3FRAF
-
-
Mashup Score: 1Cardiovascular Substructure Dose and Cardiac Events following Proton- and Photon-Based Chemoradiotherapy for Non-Small Cell Lung Cancer - PubMed - 6 month(s) ago
Proton therapy may have a significant effect on decreasing dose to individual cardiovascular substructures compared with photon therapy. There was no significant difference in heart dose or dose to any cardiovascular substructure between patients who did and did not experience post-treatment cardiac …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
RT @PennThalheimer: In honor of #LungCancerAwarenessMonth check out: https://t.co/At1LBEbPzx Published in Advances #radonc @ASTRO_org on th…
-
-
Mashup Score: 64
Original Article from The New England Journal of Medicine — Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
Source: www.nejm.orgCategories: General Medicine News, Oncologists1Tweet-
The field of Thoracic Oncology is moving faster than we can keep up! Another @NEJM article, this time on AEGEAN- first reported @AACR, now published, with full results of peri-operative Durvalumab in resectable #NSCLC @ESMO_Open #ESMO23 https://t.co/jQao1gRESw Congrats to… https://t.co/y5V3G3FRAF
-
-
Mashup Score: 64
Original Article from The New England Journal of Medicine — Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
Source: www.nejm.orgCategories: General Medicine News, Oncologists1Tweet-
The field of Thoracic Oncology is moving faster than we can keep up! Another @NEJM article, this time on AEGEAN- first reported @AACR, now published, with full results of peri-operative Durvalumab in resectable #NSCLC @ESMO_Open #ESMO23 https://t.co/jQao1gRESw Congrats to… https://t.co/y5V3G3FRAF
-
-
Mashup Score: 64
Original Article from The New England Journal of Medicine — Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
Source: www.nejm.orgCategories: General Medicine News, Oncologists1Tweet-
The field of Thoracic Oncology is moving faster than we can keep up! Another @NEJM article, this time on AEGEAN- first reported @AACR, now published, with full results of peri-operative Durvalumab in resectable #NSCLC @ESMO_Open #ESMO23 https://t.co/jQao1gRESw Congrats to… https://t.co/y5V3G3FRAF
-
-
Mashup Score: 15WCLC2023 - 8 month(s) ago
Founded in 1972, the International Association for the Study of Lung Cancer (IASLC) is an international organization of more than 8,000 lung cancer specialists from 100+ countries. IASLC members work towards developing and promoting the study of etiology, epidemiology, prevention, diagnosis, treatment and all other aspects of lung cancer. IASLC’s mission is to enhance the understanding and education of lung cancer to scientists, members of the medical community and the public. In addition to the annual meeting, the IASLC publishes the Journal of Thoracic Oncology, a prized resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer.The IASLC World Conference on Lung Cancer (WCLC) is the largest international gathering in the field of lung cancer and thoracic oncology. With a stellar scientific program and well known faculty, WCLC highlights the most advanced treatments, clinical trials and studies in thoracic oncology a
Source: meetingsapp.iaslc.orgCategories: Latest Headlines, Oncologists1Tweet-
#WCLC23 starts soon. Lots of great content on thoracic malignancies - from screening, early detection, pathology, biomarkers and new targets + drugs! Catch content online on the virtual platform: https://t.co/WFE4l92vdE @IASLC https://t.co/O2AIi1wwcP
-
#TTLC24 starts tonight with opening reception, w/keynote speaker @christine_lovly Join us in person @FairmontMiramar @IASLC https://t.co/oqUqoWU1OH or follow along virtually! @LeciaSequist @JoelNealMD @karenkellymd https://t.co/AUhBdL0nrb